Yes of course if they can pull it off but it's also been viewed that way for a long time.
It looks like the main obstacle here would be overcoming where the Janssen collaboration presumably couldn't deliver. We know that EET had worked right up to delivering Janssen cargo but as they walked out on the collaboration I guess would be fair to assume there was some obstacle with the actual delivery that they couldn't overcome & obviously had run out of ideas to get around it or weren't prepared to spend any time with it so makes sense that they have highlighted interest if it can be overcome at some point in the future. Strange decision though given that while the deal was potentially worth a lot of money it was heavily back ended so really didn't cost them much to keep it running where as assuming PYC delivers at some point in the future with IMD it would cost a lot more. Also wonder what the break downs are between PYC, IMD and any other parties if it does come through ?
Anyway heading into the end of year conference season I think we had 8 in the first half of this year & another 4 scheduled from middle of this month through to December - Miptec, Phages, BioEurope & ? something else ?
PYC Price at posting:
1.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)